News file for: Vaccine

Study Recommends Shift In Pneumonia Vaccination Strategy

Study Recommends Shift In Pneumonia Vaccination Strategy

Pneumococcal vaccination programs should focus on children with the poorest access to healthcare services, according to a study.

Sanofi Pasteur, SK Chemicals To Co-Develop Pneumococcal Vaccine

Sanofi Pasteur, SK Chemicals To Co-Develop Pneumococcal Vaccine

Vaccine-maker Sanofi Pasteur will invest US$23 million in South Korea’s SK Chemicals for the development of pneumococcal conjugate vaccine.

US$12 Million In Grants Awarded For Neglected Diseases

US$12 Million In Grants Awarded For Neglected Diseases

Japan’s Global Health Initiative Technology Fund has committed US$12 million in grants for neglected diseases and a potential tuberculosis vaccine.

Study Shows HPV Vaccine Protects Against Cervical Cancer

Study Shows HPV Vaccine Protects Against Cervical Cancer

By linking Queensland records of HPV vaccinations with the pap smear register, scientists have been able to show that vaccinations have been effective in protecting against cervical cancer.

Red Flags In China’s Disease Control

Red Flags In China’s Disease Control

China has made great strides in improving its ability to handle a public health emergency, but problems still linger in disease reporting, writes Dr. Yanzhong Huang.

Sinovac Seeks Approval For H7N9 Vaccine Clinical Trials

Sinovac Seeks Approval For H7N9 Vaccine Clinical Trials

Sinovac Biotech has submitted a clinical trial application to commence clinical trials for its vaccine Avian influenza A (H7N9) vaccine.

Takeda To Sell BIKEN’s Chickenpox Vaccine

Takeda To Sell BIKEN’s Chickenpox Vaccine

Takeda has announced a sales agreement with BIKEN to commence the sale of BIKEN’s chickenpox vaccine in Japan from February 2014.

Setback For Dengue-Blocking Mosquito Trial In Vietnam

Setback For Dengue-Blocking Mosquito Trial In Vietnam

A project to introduce mosquitoes that could potentially block dengue virus on an island off Vietnam has run into an early hurdle.

Alvogen Partially Acquires Lotus Pharma For US$200 Million

Alvogen Partially Acquires Lotus Pharma For US$200 Million

Lotus Pharmaceutical has signed a deal with US-based drug maker Alvogen Group Inc, allowing Alvogen to acquire 60 percent of its shares.

Adimmune To Begin Phase III Flu Vaccine Trials In China

Adimmune To Begin Phase III Flu Vaccine Trials In China

Taiwanese vaccine maker Adimmune Corp has received approval from the Chinese government to start Phase III clinical trials of its flu vaccine in China.